✦ LIBER ✦

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

✍ Scribed by Smolen, Josef S; Nash, Peter; Durez, Patrick; Hall, Stephen; Ilivanova, Elena; Irazoque-Palazuelos, Fedra; Miranda, Pedro; Park, Min-Chan; Pavelka, Karel; Pedersen, Ronald; Szumski, Annette; Hammond, Constance; Koenig, Andrew S; Vlahos, Bonnie

Book ID: 120575033
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 386 KB
Volume: 381
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(12)61811-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic effect of the combination of

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

✍ Lars Klareskog; Désirée van der Heijde; Julien P de Jager; Andrew Gough; Joachim 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 131 KB

Comparison of methotrexate monotherapy w

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

✍ Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; D 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 178 KB

Induction of response with etanercept–me

Induction of response with etanercept–methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study

✍ Pavelka, Karel; Szekanecz, Zoltan; Damjanov, Nemanja; Majdan, Maria; Nasonov, Ev 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 342 KB

Efficacy of methotrexate treatment in pa

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

✍ Henrike van Dongen; Jill van Aken; Leroy R. Lard; Karen Visser; H. Karel Ronday; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex

Once-weekly administration of 50 mg etan

Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Edward C. Keystone; Michael H. Schiff; Joel M. Kremer; Shelly Kafka; Michael Lov 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Abstract ## Objective To evaluate the safety, efficacy, and pharmacokinetics of 50 mg etanercept administered subcutaneously once weekly in adult patients with active rheumatoid arthritis (RA). ## Methods Four hundred twenty RA patients were randomized to receive, in a blinded manner, the stu

The influence of genetic variation in th

The influence of genetic variation in the HLA–DRB1 and LTA–TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept

✍ Lindsey A. Criswell; Raymond F. Lum; Kevin N. Turner; Blanche Woehl; Yuanqing Zh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 3 views

## Abstract ## Objective To examine the roles of specific genetic polymorphisms as predictors of response to treatment of early rheumatoid arthritis (RA). ## Methods Subjects included 457 patients with early RA (duration of ≤3 years) who participated in a randomized controlled trial comparing we